✨ Key Finding: Percutaneous coronary intervention reduced major adverse cardiac events compared to conservative treatment most significantly in TAVI patients aged 78-81 years (17% vs 42%; HR: 0.36).
✨ Key Finding: Contemporary personalized treatment strategies have reduced hypertrophic cardiomyopathy-related mortality to ≤0.5% per year, a 10-fold decrease from early estimates.
This prospective cohort study examines blood pressure trajectories in HIV-infected and uninfected adults, suggesting significant cardiovascular implications.
Clinical guidelines summarize strategies for preventing and managing hypertension in adults, indicating the importance of proper care.
The Get With the Guidelines program improves heart failure care quality, indicating effective treatment implementation for hospitalized patients.
✨ Key Finding: Conservative medical management with anticoagulation successfully treated a rare giant left atrial appendage aneurysm presenting as congestive heart failure and atrial fibrillation.
✨ Key Finding: Fontan Outcomes Network participants (n=1121) demonstrated high clinical burden, including typical adverse events in 59%, arrhythmias in 41.3%, and anxiety disorders in 34.1% of patients.
Researchers investigate microvascular repair in heart failure recovery, revealing cellular mechanisms and implications for therapy.
✨ Key Finding: Spironolactone and renal denervation decrease blood pressure in patients with true resistant hypertension, a condition affecting 10% of all treated hypertensive patients.

“【難治性高血圧】 "真の"治療抵抗性は治療高血圧患者の約10% (レビュー / JAMA / 2026) ■ポイント ①偽性抵抗性の除外(服薬不遵守・白衣効果)が先決 ②MRAが第4選択薬の軸(PATHWAY-2試験) ■注意点 → レビュー論文。推奨のエビデンスレベルを要確認 ↓論文リンク https://t.co/FGjMlh3EOS”
✨ Key Finding: The diagnostic ability of the Japanese version of the high bleeding risk (J-HBR) criteria in patients with lower extremity peripheral arterial disease remains unclear.

“In patients with lower extremity PAD undergoing EVT, the J-HBR criteria, a domestically developed risk-predicting model after PCI, successfully stratified ischemic and bleeding risks. By Yuichi Saito @saitoyuichi1984 https://t.co/0D7CWmtcz0 #circ_j #CardioX https://t.co/ub8XCGxCXa”